Open the mobile menu
The Novelty study

This website provides information and resources about the NOVEL observational longiTudinal studY (NOVELTY). This study investigates patient characteristics, treatment, burden of illness and underlying disease mechanisms in people with asthma and/or chronic obstructive pulmonary disease (COPD).

For information relevant to your needs please select from the following:



What is the NOVELTY study?

The NOVELTY study is an enhanced, multinational, prospective, observational study of patients with a diagnosis or suspected diagnosis* of asthma and/or COPD.

This study investigates patient characteristics, treatment, burden of illness and underlying disease mechanisms in people with asthma and/or chronic obstructive pulmonary disease (COPD).

*A suspected diagnosis means a patient with symptoms consistent with asthma or COPD, but who has not had diagnostic investigations or a formal diagnosis.

Veeva ID: Z4-18040 – Date of preparation: September 2019 – Date of expiry: September 2021

© AstraZeneca 2019